RESUMO
The industrial effluents discharge including heavy metals drain into the river, which has given rise to many problems of hazarding aquatic ecosystems and human health. Biosorption serves as the adsorption of heavy metals onto a natural adsorbent, it is becoming a potential alternative for toxic metals removal from industrial effluents in the last decades. The objectives of present research were to investigate the biosorption behaviors and the mechanisms of copper (Cu), zinc (Zn), cadmium (Cd) and chromium (Cr) ions, respectively onto foxtail millet shell as a new natural biosorbent in aqueous solution. The effects of pH (2.0-6.0), contact time (5.0-240.0â¯min), initial metal ions concentration (25.0-300.0â¯mg/L), particle size (0.25-2.0â¯mm) and biosorbent dosage (1.0-6.0â¯g/L) on the adsorption efficiency of the target metals using foxtail millet shell were evaluated in batch experiments. The models of isotherms and kinetics were used to assess the removal behaviors of Cu, Zn, Cd and Cr ions from aqueous solution by foxtail millet shell. The results showed that the best fitting equilibrium isotherm models for Cu, Zn, Cd and Cr ions were Freundlich (Cu and Zn) and Langmuir (Cd and Cr), respectively under the proper adsorption conditions. The maximum biosorption capacities were 11.89, 10.59, 12.48 and 11.70â¯mgâ¯g-1 of Cu, Zn, Cd and Cr, respectively by terms of Langmuir model. The kinetics of biosoption the target metal ions processes were best explained by pseudo-second-order kinetic model. Furthermore, pseudo-second-order and intraparticle diffusion models were cooperative mechanism during the whole biosorption. In addition, the pores on the surface of the shell were covered and then became smooth after biosorption through Scanning electron microscope (SEM) revealed, which demonstrated that the target metal ions were adsorbed by foxtail millet shell. The results of Energy dispersive spectrometer (EDS) further gave evidences that Cu, Zn, Cd and Cr ions were adsorbed onto surface of the adsorbent, respectively. Analysis of Fourier transform infrared spectroscopy (FTIR) demonstrated that various functional groups, such as C-H, CËO, CËC, C-O, O-S-O and Si-O groups were engaged in the interaction between foxtail millet shell and Cu, Zn, Cd and Cr ions. This paper provided evidences that foxtail millet shell was a potential and efficient biosorbent on removal of Cu, Zn, Cd and Cr ions from aqueous solutions, due to its high biosorption availability, capacity and low cost.
Assuntos
Metais Pesados/análise , Setaria (Planta)/química , Poluentes Químicos da Água/análise , Adsorção , Cádmio/análise , Cromo/análise , Cobre/análise , Difusão , Concentração de Íons de Hidrogênio , Íons , Cinética , Água/química , Zinco/análiseRESUMO
OBJECTIVE: We compared the pharmacokinetic (PK) profiles of diethylstilbestrol orally dissolving film (DES ODF) and DES-capsule as well as assessing the safety, local tolerability, taste, and disintegration time of DES ODF. MATERIALS AND METHODS: Twelve healthy male volunteers receiving a single administration of 2.0 mg of DES ODF or DES-capsule were included in the study. The tolerability, taste, and time to dissolution of DES ODF were assessed after dosing. Safety assessments included adverse events, hematology and biochemistry tests, urinalysis, vital signs, and electrocardiography. RESULTS: The PK parameters of DES ODF were all greater than those of DEScapsule. The Cmax values were 5.64 ± 1.1 and 3.4 ± 1.93 ng/mL for DES ODF and DES-capsule, respectively. Assessment of bioequivalence was based on the 90% CIs of the treatment ratios of the log-transformed Cmax, AUC0-t, and AUC0-∞ (DES ODF to DES-capsule), with the mean values being 1.93 (141 - 264), 1.24 (98 - 156), and 1.59 (121 - 207), respectively, indicating that DES ODF had a significantly high bioavailability. The mean DES ODF disintegration time was 14 ± 5 minutes. DES ODF was well tolerated and no serious adverse events or clinically relevant changes were observed. CONCLUSIONS: The DES ODF is well tolerated and better absorbed in comparison with DES-capsule.
Assuntos
Dietilestilbestrol/farmacocinética , Estrogênios não Esteroides/farmacocinética , Administração Oral , Adulto , Área Sob a Curva , Disponibilidade Biológica , Cápsulas , China , Estudos Cross-Over , Dietilestilbestrol/administração & dosagem , Dietilestilbestrol/efeitos adversos , Dietilestilbestrol/sangue , Dietilestilbestrol/química , Estrogênios não Esteroides/administração & dosagem , Estrogênios não Esteroides/efeitos adversos , Estrogênios não Esteroides/sangue , Estrogênios não Esteroides/química , Meia-Vida , Voluntários Saudáveis , Humanos , Masculino , Taxa de Depuração Metabólica , Fatores Sexuais , Solubilidade , Paladar , Equivalência Terapêutica , Adulto JovemRESUMO
Several studies have shown that hepatocyte growth factor (HGF) ameliorates chronic renal failure, but its mechanism of action is unclear. This study was designed to test the delivery of HGF in the PCI-neo vector, using the 5/6 nephrectomized rat as a model for chronic renal failure, and to confirm that this protective function is associated with decreased protein expression of transforming growth factor-beta1 (TGF-ß1). Rats were randomly divided into the following groups: Control (untreated), PCI-neo (vector control), 5/6 nephrectomy, and PCI-neo-HGF. Rats were sacrificed at both the fifth and ninth week after 5/6 nephrectomy. Kidney specimens were used for pathological examination (hematoxylin-eosin staining), and detection of TGF-ß1 protein (Western blot and immunohistochemistry) expression. Blood urea nitrogen, serum creatinine, and 24-h urinary protein excretion (UPE) were increased, renal interstitium was seriously injured, and TGF-ß1 protein expression was elevated in 5/6 nephrectomized rats compared to control rats at either time point. Red blood cell and hemoglobin levels decreased in the ninth week after 5/6 nephrectomy. PCI-neo-HGF expression ameliorated the aforementioned changes and decreased TGF-ß1 expression, not only in the fifth week, but also in the ninth week after surgery. The process of renal injury in the 5/6 nephrectomized rat was consistent with that of chronic renal failure. The increase in TGF-ß1 expression was maintained after 5/6 nephrectomy. HGF relieved chronic renal failure, this protection was associated with down-regulation of TGF-ß1 protein expression, and the protective effects were long-term and stable after 5/6 nephrectomy.
Assuntos
Fator de Crescimento de Hepatócito/farmacologia , Falência Renal Crônica/metabolismo , Falência Renal Crônica/patologia , Rim/efeitos dos fármacos , Fator de Crescimento Transformador beta1/metabolismo , Animais , Nitrogênio da Ureia Sanguínea , Western Blotting , Creatinina/sangue , Modelos Animais de Doenças , Regulação para Baixo , Contagem de Eritrócitos , Hemoglobinas/metabolismo , Imuno-Histoquímica , Rim/metabolismo , Rim/patologia , Masculino , Nefrectomia , Plasmídeos , Proteinúria , RatosRESUMO
The protective effect of erythropoietin (EPO) on tissues following ischemia and reperfusion injuries remains poorly understood. We aimed to investigate the effect of EPO in preventing endotoxin-induced organ damage. Rat model of multiple organ failure (MOF) was established by tail vein injection of 10 mg/kg lipopolysaccharide (LPS). Recombinant human EPO treatment (5000 U/kg) was administered by tail vein injection at 30 min after LPS challenge. Twenty-four h after EPO treatment, changes in serum enzyme levels, including aspartate aminotransferase (AST), alanine transaminase (ALT), blood urea nitrogen (BUN) and creatinine (Cr), were evaluated by biochemical analysis. Serum levels of tumor necrosis factor-α (TNF-α) were determined by using immunoradiometric assay. Histological examination of tissue sections was carried out by hematoxylin and eosin staining, while ultrastructure evaluation of organ tissues was assessed by transmission electron microscopy. Protein expression levels were detected by using Western blotting. EPO treatment showed a modest effect in preventing LPS-induced elevation of AST, ALT, BUN, Cr, and TNF-α levels, and in protecting against LPS-induced tissue degeneration and injured ultrastructure in the lung, liver, and kidney. Moreover, LPS promoted phosphorylation of alanine aminotransferase (AKT) and increased nuclear factor-κB (NF-κB) activation in the lung, liver, and kidney (P<0.05 vs. control). However, EPO treatment significantly decreased the LPS-induced pAKT up-regulation in these tissues (P<0.05 vs. LPS treatment alone). The present study demonstrates that EPO may play a protective role against LPS-induced MOF by reducing the inflammatory response and tissue degeneration, possibly via the phosphatidylinositol 3-kinase/AKT and NF-κB signaling pathways.
Assuntos
Eritropoetina/farmacologia , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Pulmão/efeitos dos fármacos , Insuficiência de Múltiplos Órgãos/prevenção & controle , Alanina Transaminase/sangue , Animais , Aspartato Aminotransferases/sangue , Nitrogênio da Ureia Sanguínea , Western Blotting , Creatinina/sangue , Endotoxinas , Eritropoetina/administração & dosagem , Eritropoetina/genética , Injeções Intravenosas , Rim/metabolismo , Rim/ultraestrutura , Lipopolissacarídeos , Fígado/metabolismo , Fígado/ultraestrutura , Pulmão/metabolismo , Pulmão/ultraestrutura , Masculino , Microscopia Eletrônica de Transmissão , Insuficiência de Múltiplos Órgãos/sangue , Insuficiência de Múltiplos Órgãos/induzido quimicamente , NF-kappa B/metabolismo , Fosforilação/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-akt/metabolismo , Ratos , Ratos Wistar , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/farmacologia , Fator de Necrose Tumoral alfa/sangueRESUMO
This study aimed to examine whether hepatocyte growth factor (HGF) can improve renal function in 5/6 nephrectomized rats and investigate whether this function is associated with a decrease in α-smooth muscle actin (α-SMA) expression in rat glomerulus mesangial cells and renal interstitium. Rats were randomly divided into the following groups: control, PCI-neo, sham-operation, 5/6 nephrectomy, and low-dose and high-dose PCI-neo-HGF. Rats were killed in the ninth week after 5/6 nephrectomy, and the kidney specimens were subjected to pathological examination by Hematoxylin-Eosin staining and detection of α-SMA expression by reverse transcriptase-polymerase chain reaction (RT-PCR), Western blot, and immunohistochemistry. The results showed that blood urea nitrogen and serum creatinine levels were increased, renal interstitium was injured, and α-SMA expression was elevated in 5/6 nephrectomized rats compared with that in control. The above changes were ameliorated in the rats injected with PCI-neo-HGF vector. At the molecular level we found that PCI-neo-HGF repressed α-SMA expression in mesangial cells stimulated by lipopolysaccharide. In conclusion, our data suggest that HGF can relieve chronic renal failure, and this protection is associated with the down-regulation of α-SMA expression in mesangial cells and renal interstitium.
Assuntos
Actinas/metabolismo , Fator de Crescimento de Hepatócito/uso terapêutico , Falência Renal Crônica/tratamento farmacológico , Células Mesangiais/metabolismo , Proteinúria/tratamento farmacológico , Animais , Células Cultivadas , Colágeno Tipo I/metabolismo , Imuno-Histoquímica , Rim/patologia , Falência Renal Crônica/metabolismo , Falência Renal Crônica/patologia , Lipopolissacarídeos , Masculino , Nefrectomia , Proteinúria/metabolismo , RNA Mensageiro/metabolismo , Ratos , Transfecção , Fator de Crescimento Transformador beta1/antagonistas & inibidoresRESUMO
Several studies have shown that hepatocyte growth factor (HGF) ameliorates renal interstitial fibrosis, but the mechanism is not fully clear. This study was designed to examine whether HGF can relieve renal interstitial injury in 5/6 nephrectomized rats, and to confirm whether this function was associated with decrease in alpha-smooth muscle actin (alpha-SMA) and transforming growth factor-betal (TGF-beta1) expression. The animals were randomized into 8 groups comprising 6 animals (n = 6) each: control (group I), PCI-neo (group II, 900 microg), sham-operation (group III, not nephrectomy), model or 5/6 nephrectomy group (group IV), lotensin group (an angiotensin converting enzyme inhibitor, group V, 0.6 mg/100 g/day for 5 weeks), low-dose PCI-neo-HGF group (group VI, 690 microg), high-dose PCI-neo-HGF group (group VII, 1380 microg) and lotensin + high-dose PCI-neo-HGF group (group VIII, 0.6 mg/100 g/day for 5 weeks, 1380 microg). The animals were sacrificed in the 5th week after 5/6 nephrectomy. The specimens of kidneys were used for pathological examination (hematoxylin-eosin staining), detection of alpha-SMA and TGF-beta1 mRNA (Reverse transcriptase-polymerase chain reaction) and protein (Western blot and immunohistochemistry) expression. The results showed that in 5/6 nephrectomized rats blood urea nitrogen (BUN), serum creatinine (CRE) and 24 h urinary albumin excretion (UAE) were increased, renal interstitium was injured seriously and alpha-SMA, TGF-beta1 mRNA and protein expression were elevated compared with those of control. The above changes were ameliorated and alpha-SMA and TGF-beta 1 expression was reduced by both PCI-neo-HGF and lotensin. The lotensin + high-dose PCI-neo-HGF group rats exhibited the most significant therapeutic effect both in decreasing the BUN, CRE and 24 h UAE and in relieving renal interstitial injury. In conclusion, the study demonstrated that HGF can relieve renal interstitial injury and this protection was associated with down-regulation of a-SMA and TGF-beta 1 expressions.
Assuntos
Actinas/efeitos dos fármacos , Fator de Crescimento de Hepatócito/uso terapêutico , Nefropatias/tratamento farmacológico , Rim/patologia , Fator de Crescimento Transformador beta1/efeitos dos fármacos , Actinas/metabolismo , Animais , Fibrose/tratamento farmacológico , Fibrose/metabolismo , Fibrose/patologia , Fator de Crescimento de Hepatócito/farmacocinética , Nefropatias/metabolismo , Masculino , Distribuição Aleatória , Ratos , Fator de Crescimento Transformador beta1/metabolismoRESUMO
We observe and analyze multiple Fano resonances and the plasmon-induced transparency (PIT) arising from waveguidecoupled surface plasmon resonance in a metal-dielectric Kretschmann configuration. It is shown that the simulation results for designed structures agree well with those of the dispersion relation of waveguide theory. We demonstrate that the coupling between the surface plasmon polariton mode and multi-order planar waveguide modes leads to multiple Fano resonances and PIT. The obtained results show that the number of Fano resonances and the linewidth of resonances depend on two structural parameters, the Parylene C and SiO2 layers, respectively. For the sensing action of Fano resonance, the figure of merit for the sensitivity by intensity is estimated to be 44 times higher than that of conventional surface plasmon resonance sensors. Our research reveals the potential advantage of sensors with high sensitivity based on coupling between the SPP mode and multi-order PWG modes.